The bacterial cells were grown in 20 mL BHI broth to logarithmic stage (OD600nm = 0.6), and harvested by centrifugation. The cell pellet was suspended in 20 mL of 4% SDS, and inactivated at 65°C for 2 h. The inactivated cell suspension was centrifuged, and the cells were washed with deionized water three times. The washed cell pellet was suspended with PBS to reach 0.4 OD600nm, and then tested for susceptibility to commercially available lysostaphin (E. coli recombinant, Prospec, Ness-Ziona, Israel) or mutanolysin (recombinant, A&A Biotechnology, Gdynia, Poland) lytic enzyme. Lysostaphin and mutanolysin were added to 1 mL of the tested cell suspension at a final concentration of 8 μg/mL and 0.2 U/mL, respectively, followed by incubation in a plastic cuvette at 30°C at 120 rpm rotation. The reduction in OD by cell lysis was measured using a DU730 spectrophotometer (Beckman Coulter, CA, United States).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.